Author

Nico Preising

Universität Ulm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Organism:mouse· 1 Approach:statistical model· 1 Organism:zebrafish· 1

Frequent Co-Authors

Ludger StändkeriD· 5 shared Armando RodrígueziD· 3 shared Frank KirchhoffiD· 3 shared Sebastian WieseiD· 3 shared Elsa Sánchez‐GarcíaiD· 2 shared Fabian ZechiD· 2 shared Gilbert WeidingeriD· 2 shared Jan MünchiD· 2 shared

Activity by Year

2020-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMicrobiology

Ludger StändkerORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Laudanosine restricts Ebola virus entry by targeting TPC2-dependent endolysosomal trafficking

Tom Seitz, Julian Köngeter, Susanne Klute, Franziska Kraft, Denise Christine Clesle, Lily Tschampel, Nico Preising, Armando Rodríguez Alfonso, Sebastian Wiese, Ludger Ständker, Christoph Jung, Timo Jacob, Janet Köhler, Gilbert Weidinger, Nadine Biedenkopf, , Fabian Zech

The paper identifies Laudanosine as an inhibitor of TPC2-dependent viral entry, effective against Ebola and related viruses without cytotoxicity.

bioRxiv · Jun 18, 2026 · PreprintMicrobiology

Bad bugs, new drugs: The antimicrobial peptide C14R is active against the ESKAPE pathogens

Daniel Gruber, Verena Vogel, Jan-Christoph Walter, Sabine Szunerits, Armando Rodríguez, Nico Preising, Ludger Ständker, Carolina Firacative, Barbara Spellerberg, Ann‐Kathrin Kissmann, Frank Rosenau

This study evaluates the antimicrobial peptide C14R against ESKAPE pathogens, showing potent bactericidal activity and biofilm inhibition.

bioRxiv · Dec 16, 2025 · PreprintMicrobiology

Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum 1 Efficacy Against Corona and Influenza Viruses

Jan Lawrenz, Lukas Wettstein, Armando Rodríguez, Rayhane Nchioua, Pascal von Maltitz, Dan Albers, Fabian Zech, Julie Vandeput, Lieve M. J. Naesens, Giorgio Fois, Veronika Neubauer, Nico Preising, Emilia Schmierer, Yasser Almeida‐Hernández, Moritz Petersen, , Jan Münch

This paper identifies Trypstatin, a Kunitz-type protease inhibitor that inhibits TMPRSS2 and related proteases, showing broad-spectrum antiviral activity against SARS-CoV-2, influenza, and other respiratory viruses.

Advanced Science · May 14, 2025Peer-reviewedMicrobiology

Retinol Binding Protein 4 reactivates latent HIV-1 via the JAK/STAT5 and JNK pathways

Chiara Pastorio, Khumoekae Richard, Manuel Hayn, Lennart Koepke, Andrea Preising, Nico Preising, Ludger Ständker, Matthew G. Fair, Jessicamarie Morris, Emmanouil Papasavvas, Honghong Sun, Armando Rodríguez, Karam Mounzer, Sebastian Wiese, Pablo Tebas, , Frank Kirchhoff

This study identifies Retinol Binding Protein 4 (RBP4) as a natural activator of latent HIV-1 through JAK/STAT5 and JNK pathways, offering a new strategy for reactivating viral reservoirs.

bioRxiv · Feb 26, 2025 · PreprintImmunology

Biomolecular models of EPI-X4 binding to CXCR4 allow the rational optimization of peptides with therapeutic potential

Pandian Sokkar, Mirja Harms, Christina Martina Stürzel, Andrea Gilg, Gönül Kızılsavaş, Martina Raasholm, Nico Preising, Manfred Wagner, Ludger Ständker, Gilbert Weidinger, Jan Münch, Elsa Sánchez‐García

The paper investigates how EPI-X4 binds to CXCR4 using simulations and experiments, leading to the design of more potent and safer CXCR4 antagonists.

bioRxiv · Oct 23, 2020 · PreprintMolecular Biology